SPRR1A and neoplasm: We found that the concentration of SPRR1A was significantly higher in tumour samples from patients without concomitant diseases, compared to samples from patients with concomitant diseases (5.893 (1.854–13.560) vs. 0.667 (0.334–1.982); p = 0.0165), as presented in Figure 8.